Pulse Biosciences Inc. has announced new inducement grants for its newly hired principal accounting officer, Steven T. Weber, and four other employees. These grants, approved by the company's Compensation Committee, involve options to acquire up to 68,217 shares of the company's common stock, beyond the existing 2017 Equity Incentive Plan, under the 2017 Inducement Equity Incentive Plan. Mr. Weber's options, totaling up to 27,500 shares, are split evenly between time-based vesting over four years and performance-based objectives tied to market-capitalization milestones. The options, with an exercise price of $16.03 per share, were issued in compliance with Nasdaq Listing Rule 5635(c)(4).
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pulse Biosciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250716986624) on July 16, 2025, and is solely responsible for the information contained therein.